Fagotti, Anna
 Distribuzione geografica
Continente #
NA - Nord America 249
EU - Europa 114
AS - Asia 36
AF - Africa 5
SA - Sud America 3
Totale 407
Nazione #
US - Stati Uniti d'America 246
IT - Italia 72
DE - Germania 20
CN - Cina 13
PL - Polonia 8
VN - Vietnam 6
IN - India 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CA - Canada 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GB - Regno Unito 2
ID - Indonesia 2
RO - Romania 2
TW - Taiwan 2
UA - Ucraina 2
ZA - Sudafrica 2
BE - Belgio 1
CL - Cile 1
CO - Colombia 1
ES - Italia 1
FI - Finlandia 1
FR - Francia 1
IE - Irlanda 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
MX - Messico 1
NL - Olanda 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 407
Città #
Fairfield 43
Woodbridge 26
Cambridge 19
Cattolica 19
Houston 19
Wilmington 17
Ashburn 16
Santa Cruz 16
Buffalo 15
Seattle 15
Rome 12
Milan 11
Ann Arbor 10
Warsaw 8
Beijing 4
Genazzano 4
Hangzhou 4
Hanoi 4
Salò 4
San Diego 4
University Park 4
Busto Arsizio 2
Clearwater 2
Dhaka 2
Dong Ket 2
Fremont 2
Hyderabad 2
Kiel 2
Las Vegas 2
Los Angeles 2
Muizenberg 2
Ottawa 2
Wuhan 2
Andria 1
Beirut 1
Boardman 1
Chicago 1
Clarkesville 1
Dublin 1
Easton 1
Gaza 1
Guangzhou 1
Inveruno 1
Lake Forest 1
Lappeenranta 1
Lima 1
Louvain 1
Milpitas 1
New York 1
Paderno Dugnano 1
Peoria 1
Phoenix 1
Prague 1
Riva 1
Salem 1
San Jose 1
Santa Maria 1
Santiago 1
Shenyang 1
Tokyo 1
Washington 1
Totale 326
Nome #
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials., file e309db6d-d5de-0599-e053-3705fe0a55db 200
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies, file e309db6c-336d-0599-e053-3705fe0a55db 70
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data, file e309db6e-ee9f-0599-e053-3705fe0a55db 33
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience, file e309db6c-335d-0599-e053-3705fe0a55db 23
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series, file e309db6c-3101-0599-e053-3705fe0a55db 22
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study, file e309db6c-3187-0599-e053-3705fe0a55db 11
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study, file e309db6e-45b7-0599-e053-3705fe0a55db 9
Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience, file d16a01d7-169d-4021-976a-e5474c4e9e79 8
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome., file e309db6d-7e6e-0599-e053-3705fe0a55db 6
Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis, file fe31838b-5eb2-4b9e-8e98-39d10cbdf292 6
Visual Peritoneal Evaluation of Residual Disease After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Patients: The VIPER Study, file d28b1bb3-46ab-44df-9fd4-b5e980264150 3
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases, file e309db6d-b8f3-0599-e053-3705fe0a55db 3
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease, file e983298d-187f-44a6-afaf-aa9fd4d9bf2f 3
Nomogram to predict feasibility of minimally invasive interval debulking surgery in advanced ovarian cancer, file 1693ef83-f292-4c7d-934f-f7d232d58662 2
New windows of surgical opportunity for gynecological cancers in the era of targeted therapies, file 1a36ff8e-2769-4544-be6d-05b95a697a18 2
Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO), file 5a0b808a-20b2-4e08-94c7-94a5612af3e7 2
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings, file 1b5548bc-f237-411b-9a18-4ebaee6336d0 1
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach, file af1235e6-84ba-470d-ba33-c7aa8950e47a 1
Lymph node staging in grade 1–2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?, file b336c599-987e-4a5c-9ef5-b63c449777e5 1
The impact of secondary cytoreductive surgery in platinum sensitive recurrent ovarian cancer treated with upfront neoadjuvant chemotherapy and interval debulking surgery, file b445811e-f41c-49c2-b79a-f9342384556b 1
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer, file b9f2136e-f08f-4df5-8116-0e9ab7bdca35 1
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer, file ba0129aa-4b70-4109-ae13-4e3d754e65dd 1
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance, file d30014da-3e56-4e3e-bd44-b87bfc1edd20 1
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience, file e309db6f-0d7e-0599-e053-3705fe0a55db 1
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept, file e309db6f-4b9a-0599-e053-3705fe0a55db 1
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival, file e309db6f-5a3f-0599-e053-3705fe0a55db 1
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments, file e309db6f-6f3d-0599-e053-3705fe0a55db 1
Optimizing the number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma: A propensity-score matching analysis, file e309db6f-7047-0599-e053-3705fe0a55db 1
Totale 415
Categoria #
all - tutte 1.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.073


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 0 9 9
2019/2020114 2 1 30 44 6 6 5 5 8 1 4 2
2020/202149 9 0 4 1 6 5 9 1 2 2 4 6
2021/202252 2 8 0 3 3 1 5 1 5 3 15 6
2022/202345 2 0 12 8 1 2 5 1 6 0 1 7
2023/202427 0 1 2 2 0 3 0 1 2 16 0 0
Totale 415